ArticlemSphere2020
High Prevalence of Colistin-Resistant Escherichia coli with Chromosomally Carried
Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.
- Guts of healthy humans, livestock, and pets harbor critical-priority and high-risk Escherichia coli clones.Epidemiology and health · 2025Pooled it
- The colistin resistance pandemic: A dual threat from plasmid-encoded mobilised colistin resistance genes and chromosomal mutations.African journal of laboratory medicine · 2026Review
- A Monitoring Method to Evaluate the Accumulation of Antimicrobial-Resistance Genes in Gram-Negative Bacteria Distributed in Environmental Water.Environmental microbiology reports · 2025Article
- Epidemiology, genetic dynamics, and transmission of theEmerging microbes & infections · 2025Article
- One Health at Risk: Plasmid-Mediated Spread ofAntibiotics (Basel, Switzerland) · 2025Review
- Genetic characterization of multidrug-resistantFrontiers in cellular and infection microbiology · 2024Article
- Characterization of the Antimicrobial Activities ofPharmaceutics · 2023Article
- Genetic characteristic of coexisting ofFrontiers in microbiology · 2023Article
- Article
- Worldwide Prevalence ofPathogens (Basel, Switzerland) · 2022Review
- Horizontal transfer of a plasmid possessing mcr-1 marked with a single nucleotide mutation between Escherichia coli isolates from community residents.BMC research notes · 2022Article
- Characterization of Genetic Elements CarryingMicrobiology spectrum · 2022Article
- Colistin Resistance Mechanisms in HumanAntibiotics (Basel, Switzerland) · 2022Article
- Antimicrobial resistance surveillance ofFrontiers in microbiology · 2022Article
- Spread of theFrontiers in microbiology · 2022Article
- Characterisation of Colistin -Resistant Enterobacterales andAntibiotics (Basel, Switzerland) · 2021Article
- Genomic Insights into a Colistin-Resistant UropathogenicMicroorganisms · 2021Article
- A Large Spatial Survey of Colistin-Resistant GeneMicroorganisms · 2021Article
- Emergence of Nosocomial Pneumonia Caused by Colistin-ResistantAntibiotics (Basel, Switzerland) · 2021Article
- Comparative Genome Analysis of Livestock and Human Colistin-ResistantInfection and drug resistance · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The wide distribution of colistin-resistant bacteria in developing countries has become a common phenomenon. To understand the mechanisms underlying their distribution, we studied the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.